6533b851fe1ef96bd12a9860

RESEARCH PRODUCT

Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma

Felipe-fornias SperandioEduardo-pereira GuimarãesJoão-adolfo-costa HanemannAlessandro-antônio-costa PereiraMarina-lara De Carli

subject

AdultMalePathologymedicine.medical_specialtyTongue squamous cell carcinomaOdontologíaDiseaseCyclin D1TonguemedicineHumansCyclin D1Tongue NeoplasmGeneral DentistryGrading (tumors)AgedNeoplasm StagingOral Medicine and Pathologybiologybusiness.industryResearchMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludTongue NeoplasmsKi-67 Antigenmedicine.anatomical_structureOtorhinolaryngologyKi-67UNESCO::CIENCIAS MÉDICASCarcinoma Squamous Cellbiology.proteinImmunohistochemistryFemaleSurgerybusiness

description

Background The immunohistochemical expression of Cyclin D1 and Ki-67 were analyzed in tongue squamous cell carcinomas (SCC), relating them to the clinical and morphological exhibition of these tumors. Material and Methods Twenty-nine patients fulfilled the inclusion criteria; clinical data included gender, age, ethnicity and use of licit drugs such as alcohol and tobacco. The TNM staging and histopathological differentiation grading was assessed for each case. In addition, T1 patients were gathered with T2 patients; and T3 patients were gathered with T4 patients to assemble two distinct groups: (T1/T2) and (T3/T4). Results The mean follow-up time was 24 months and 30% of the patients died as a consequence of the disease, while 23.3% lived with the disease and 46.7% lived lesion-free. T1 and T2 tumors showed statistically lesser Ki-67 and Cyclin D1 staining when compared to T3 and T4 tumors. Conclusions Ki-67 and Cyclin D1 pose as auxiliary tools when determining the progression of tongue SCC at the time of diagnosis. Key words:Carcinoma, squamous cell, cyclin D, immunohistochemistry, Ki-67 antigen, prognosis.

https://doi.org/10.4317/medoral.20601